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Abstract – For nanomedicine applications, there is a need 
to design advanced and cost-effective coatings, resistant 
to protein adsorption leading to increased biodistribution 
in vivo. In this study, phosphonate poly(ethylene glycol) 
copolymers were synthesized and used to coat 6nm and 
13nm iron oxide particle. In vitro, PEGylated particles 
exhibit exceptional stability and low cellular uptake, of 
the order of 100 femtograms of iron per cell. In vivo, we 
developed an in vivo Dynamic Susceptibility Weighted 
MRI (7T) protocol to monitor the hepatic capture and 
clearance of the particles injected to mice as a function 
of the time. PEGylated coat of molecular weight 2000 
gmol-1 show a 2hrs delay to liver uptake as compared to 
the commercially available USPIO Cliavist, indicating a 
direct correlation between the surface properties of the 
contrast agents and their stealthiness. 
 
Index terms– Magnetic Resonance Imaging, 
Nanomedicine, Contrast agents USPIO, PEG, polymer 
coating. 
 
I. INTRODUCTION 
 
Cancer is the second leading cause of premature deaths in 
Europe, after cardiovascular diseases [1]. Magnetic 
Resonance Imaging (MRI) enables to have precise 
information about the size, the location and the spread of 
the tumor in order to diagnose it as fast as possible. In most 
applications intrinsic contrast is sufficient to obtain a well 
contrasted image with MRI, but in almost 40% of clinical 
studies, extrinsic contrast agents able to enhance the signal 
of the lesions are required.  
Iron oxide nanoparticles offer many properties that make 
them attractive as MRI contrast agents [3].  
When disperse in biological fluids (plasma, lung fluid), 
engineered nanoparticles are selectively coated with 
proteins, resulting in the formation of a protein corona, 
recognition by the RES and a rapid cellular capture. For 
imaging applications, there is a need to design advanced 
and cost-effective coatings that are resistant to protein 
adsorption and that increase the biodistribution in vivo. In 
this study, engineered copolymers made with 
poly(ethylene glycol) and phosphonate anchors were 
synthesized and used to coat 6 nm iron oxide particles [1]. 
MRI dynamic methods have been developed to study their 
biodistribution in the liver, especially their liver uptake and 
release, giving indications on the nanoparticle stealthiness. 
 
II. MATERIALS AND METHODS 
II.1. Nanoparticles: the iron oxide nanoparticles were 
received from Paris 6. They were synthesized according 
to the Massart method (3). The nanoparticles were then 
size-sorted by subsequent phase separation. For this 
study, two batches of -Fe2O3 nanoparticles with 
diameters of 6.8 nm and 13.2 nm were synthesized. 
Polymers and coating: The phosphonate PEG 
copolymers were synthesized by SPECIFIC POLYMERS 
(http://www.specificpolymers.fr/) to supply mixed 
dispersions of 6.8 and 13.2 nm iron oxide nanoparticles.  
The copolymer composition was optimized to provide 
simple and scalable protocols as well as long-term 
stability in culture media. 
 
Nanoparticles characterization: Dynamic Light 
Scattering (DLS) was performed to measure the DH of 
nanoparticles. Ultra-Violet (UV) spectrometry was 
performed on a Varian Cary 50 scan to measure the iron 
concentration. 
 
II.3. Cytotoxicity Assay 
The cytotoxicity of USPIOs are analyzed in vitro by a WST 
assay on hepatocytes. 
II.4. Stability: All the samples were diluted to obtain a 
concentration of 1 mM to be analyzed for DH during 2 h 
and at 24 h, and 1 week. The stability of the nanoparticles 
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was assessed by measuring the DH with DLS as a function 
of the time. 
II.4. In vitro studies 
Relaxivities r1 and r2 of USPIOs were measured in saline 
and cells culture medium at 7T. 
II.5. In vivo studies 
In vivo, we developed an in vivo Dynamic 
Susceptibility Weighted MRI (7T) protocol to monitor the 
hepatic capture and clearance of the particles injected to 
Balbc C mice as a function of the time. 
 
III. RESULTS 
 
In vitro, PEGylated particles exhibit long-term stability in 
biological media and low cellular uptake, of the order of 
100 femtograms of iron per cell.  
Figure 1 : Photos of the nanoparticles in DMEM. Macro aggregates can 
be seen for the bare nanoparticles and the 13.2 nm citrate nanoparticle 
(red arrows). 
 
In vivo, Dynamic Susceptibility Weighted MRI (7T) 
protocol to monitor the hepatic uptake and clearance of the 
particles injected to Balbc C mice as a function of the time 
demonstrated that commercial contrast agents (such as 
Cliavist) were captured by the liver within 5 minutes after 
injection. With a PEGylated coat of molecular weight 2000 
g mol-1, the capture was postponed by 2 hours and the 
uptake level lower, showing a direct correlation between 
the surface properties of the contrast agents and the 
biodistribution.  
 
IV. DISCUSSION – CONCLUSION 
 
The present survey demonstrates that the surface chemistry 
of engineered particles is a key parameter in the 
interactions with cells. This work demonstrates that the 
functionalization by PEG and phosphonate groups to be 
attached to the particles is an effective way to develop 
highly stable nanoparticles and to increase their circulation 
time in blood. The RES uptake is delayed, allowing the 
particles to stay longer in the blood pool. Thus, these new 
PEG polymer coated nanoparticles open up new avenues 
for detection of tumors with MRI. 
 
Figure 2: Liver sections of mice at different time points (pre-injection, 
30min, 1h and 3h). On the left hand-side, Cliavist was injected, on the 
right hand-side, 6.8 nm PEGylated iron oxide nanoparticles was 
injected. An hyposignal is observed in both cases but at different time 
point. 
 
Beyond applications to imaging and nanomedicine, the 
approach also opens up new avenues for the efficient 
functionalization of inorganic surfaces. 
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